# Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

> **NCT07123467** · PHASE3 · RECRUITING · sponsor: **Wayne State University** · enrollment: 90 (estimated)

## Conditions studied

- Generalized Anxiety Disorder (GAD)
- Anxiety Disorders

## Interventions

- **DRUG:** Low-Dose Cannabidiol
- **DRUG:** Placebo Matched to Moderate-Dose Cannabidiol
- **DRUG:** Moderate-Dose Cannabidiol
- **DRUG:** Placebo Matched to Low-Dose Cannabidiol

## Key facts

- **NCT ID:** NCT07123467
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07123467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07123467, "Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07123467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*